Two Sigma Advisers
LSTA icon

Two Sigma Advisers’s Lisata Therapeutics LSTA Stock Holding History

Two Sigma Advisers’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,587
Closed -$36K – 2659
2022
Q2 		$36K Sell
4,587
-4,586
-50% -$37.7K ﹤0.01% 2507
2022
Q1 		$99K Sell
9,173
-6,654
-42% -$76.1K ﹤0.01% 2506
2021
Q4 		$200K Buy
+15,827
New +$244K ﹤0.01% 2288
2021
Q2 		– Sell
-907
Closed -$26K – 2586
2021
Q1 		$26K Sell
907
-3,600
-80% -$109K ﹤0.01% 2519
2020
Q4 		$97K Buy
+4,507
New +$107K ﹤0.01% 2271

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's LSTA Position: Q3 2022 in Review

Two Sigma Advisers sold out of Lisata Therapeutics (LSTA) in Q3 2022, closing a stake of 4,587 shares — an estimated $36K sold.

Two Sigma Advisers first reported a position in LSTA in Q4 2020 and held it in 5 quarters. The position peaked at $200K in Q4 2021. 22 funds tracked by Wall St. Rank hold LSTA as of Q3 2022.

  • Two Sigma Advisers reported no remaining Lisata Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 4,587 Lisata Therapeutics shares in Q3 2022, an estimated $36K.
  • Two Sigma Advisers first reported a position in Lisata Therapeutics in Q4 2020 and held it in 5 quarters.
  • Two Sigma Advisers's Lisata Therapeutics position peaked at $200K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.